Paul Lemire serves as Executive at AIkido Pharma Inc., where they oversee executive responsibilities. Since joining the company, Paul Lemire has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 26, 2022 involved receiving (via award) 8,000 shares valued at $48.0K.
Paul Lemire currently holds 12,411 shares of AIkido Pharma Inc. (AIKI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Lemire has been a net neutral trader of AIKI stock. They have purchased $0 and sold $0 worth of shares.
Paul Lemire's most recent insider trade was on Aug 26, 2022, when they sold 8,000 shares at $6.00 per share.
Get notified when new Form 4 filings are submitted
| $0.88 |
| Discretionary |